Trevi Therapeutics (TRVI) Insider Trading & Ownership $2.94 -0.12 (-3.92%) (As of 10/31/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Trevi Therapeutics (NASDAQ:TRVI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage24.37%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$349,116.96 Get TRVI Insider Trade Alerts Want to know when executives and insiders are buying or selling Trevi Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TRVI Insider Buying and Selling by Quarter Ad Porter & CompanyI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Trevi Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/9/2024Jennifer L GoodCEOSell1,840$3.04$5,593.60 9/6/2024Jennifer L GoodCEOSell4,219$3.03$12,783.57 9/4/2024Jennifer L GoodCEOSell10,981$3.02$33,162.62 8/27/2024David P MeekerDirectorSell4,555$2.93$13,346.15 8/16/2024Thomas SciasciaInsiderSell18,660$2.76$51,501.60 8/14/2024Thomas SciasciaInsiderSell100$2.75$275.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/29/2024Thomas SciasciaInsiderSell53,368$2.55$136,088.40 5/22/2024Lisa DelfiniCFOSell4,350$2.64$11,484.00 5/20/2024Jennifer L GoodCEOSell25,037$2.86$71,605.82 5/10/2024Jennifer L GoodCEOSell4,578$2.90$13,276.20 (Data available from 1/1/2013 forward) TRVI Insider Trading Activity - Frequently Asked Questions Who is on Trevi Therapeutics's Insider Roster? The list of insiders at Trevi Therapeutics includes David P Meeker, Jennifer L Good, Lisa Delfini, Paul Edward Walker, Thomas Sciascia, and Tpg Gp A, Llc. Learn more on insiders at TRVI. What percentage of Trevi Therapeutics stock is owned by insiders? 24.37% of Trevi Therapeutics stock is owned by insiders. Learn more on TRVI's insider holdings. Which Trevi Therapeutics insiders have been selling company stock? The following insiders have sold TRVI shares in the last 24 months: David P Meeker ($13,346.15), Jennifer L Good ($136,421.81), Lisa Delfini ($43,329.30), and Thomas Sciascia ($187,865.00). How much insider selling is happening at Trevi Therapeutics? Insiders have sold a total of 141,369 Trevi Therapeutics shares in the last 24 months for a total of $380,962.26 sold. Trevi Therapeutics Key ExecutivesMs. Jennifer L. Good (Age 59)Co-Founder, CEO, President & Director Compensation: $781.85k5 recent tradesDr. Thomas R. Sciascia M.D. (Age 71)Co-Founder & Chief Science Officer Compensation: $530.48kDr. David J. Clark A.F.P.M. (Age 59)M.D., M.R.C.P., Chief Medical Officer Compensation: $325.39kMs. Lisa Delfini (Age 54)Chief Financial Officer 1 recent tradesMr. Christopher Galletta (Age 46)Controller & Chief Accounting Officer Katie McManusCommunications ManagerMr. Farrell Simon Pharm.D.Chief Commercial OfficerMs. Danine Summers (Age 66)Vice President of Medical Affairs More Insider Trading Tools from MarketBeat Related Companies Vanda Pharmaceuticals Insider Transactions VYNE Therapeutics Insider Transactions Cara Therapeutics Insider Transactions Rapport Therapeutics Insider Transactions Relay Therapeutics Insider Transactions Prothena Insider Transactions Pliant Therapeutics Insider Transactions Cronos Group Insider Transactions Sana Biotechnology Insider Transactions Dianthus Therapeutics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Big Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics PartnersInsider Selling is not a Signal to Start Selling Gartner Stock2 Stocks to Buy and 1 to Sell - Smart Moves for Investors3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside This page (NASDAQ:TRVI) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trevi Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
